Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vividion Therapeutics
Biotech
Illumina nets new CEO—Chutes & Ladders
Illumina names new CEO after stormy summer. Biogen taps new research head. Novartis CCO steps down as executive musical chairs continues.
Max Bayer
,
Gabrielle Masson
Sep 8, 2023 9:30am
Bayer's acting BD chief lobbies for the job by making deals
May 24, 2023 3:00am
Former Seagen CEO takes on new role—Chutes & Ladders
Mar 24, 2023 9:30am
J&J CMO to leave after 20-year executive tenure—Chutes & Ladders
Jan 27, 2023 9:30am
Bayer's Vividion pens $930M biobucks pact with Tavros
Oct 12, 2022 7:30am
To make '1+1=3,' Bayer spends $1.5B for 'undruggables'
Aug 5, 2021 1:30am
